Novartis Issues Voluntary US Nationwide Recall of Two Lots of Sandimmune® Oral Solution (Cyclosporine Oral Solution, USP), 100 mg/mL Due to Crystallization

Novartis is conducting a voluntary nationwide recall at the consumer level of two lots of its Sandimmune® Oral Solution (cyclosporine oral solution, USP), 100 mg/mL in the US due to crystal formation observed in some bottles, which could potentially result in incorrect dosing. The issue was identifi

Related Keywords

United States ,America Sloan Simpson ,Michael Meo ,Julie Masow ,Marlena Abdinoor ,Company Contact Information ,Drug Administration ,Novartis Pharmaceuticals Corporation ,Novartis Customer Interaction Center ,Twitter ,Company Announcement ,Company Name ,Exchange Commission ,Novartis ,Announcement Date ,Oral Solution ,Sandimmune Oral Solution ,Watch Adverse Event Reporting ,East Hanover ,